Andersen H R, Nielsen J C, Thomsen P E, Thuesen L, Vesterlund T, Pedersen A K, Mortensen P T
Department of Cardiology, Skejby Sygehus, Aarhus University Hospital, Aarhus, Denmark.
Circulation. 1998 Sep 29;98(13):1315-21. doi: 10.1161/01.cir.98.13.1315.
It has been claimed that patients with sick sinus syndrome have an increased risk of developing AV block, but this has never been assessed prospectively. The aim of the present study was to evaluate in a prospective trial AV conduction during the long-term follow-up of patients with sick sinus syndrome.
Two hundred twenty-five consecutive patients with sick sinus syndrome and intact AV conduction were randomized to undergo single-chamber atrial pacing (110 patients) or single-chamber ventricular pacing (115 patients). Follow-up after 3 months and then yearly included measurement of the PQ interval and, in patients with atrial pacemakers, determination of the atrial stimulus-Q intervals at pacing rates of 100 and 120 bpm. The occurrence of AV block in the atrial group was recorded. During follow-up (mean, 5.5+/-2.4 years), there was no change in PQ interval in either group and no change in atrial stimulus-Q intervals or Wenckebach block point in the atrial group. Four of 110 patients in the atrial group developed grade 2 to 3 AV block that required upgrading of the pacemaker (0.6% per year). Two of these 4 patients had right bundle-branch block at pacemaker implantation.
AV conduction, estimated as PQ interval and atrial stimulus-Q interval at atrial pacing rates of 100 and 120 bpm and the Wenckebach block point, remains stable during long-term follow-up. Thus, treatment with single-chamber atrial pacing is safe and can be recommended to patients with sick sinus syndrome without bundle-branch block.
据称,病态窦房结综合征患者发生房室传导阻滞的风险增加,但这从未得到前瞻性评估。本研究的目的是在一项前瞻性试验中评估病态窦房结综合征患者长期随访期间的房室传导情况。
225例连续的房室传导正常的病态窦房结综合征患者被随机分为接受单腔心房起搏(110例患者)或单腔心室起搏(115例患者)。3个月后随访,然后每年随访,包括测量PQ间期,对于植入心房起搏器的患者,测定起搏频率为100次/分和120次/分时的心房刺激-Q间期。记录心房组房室传导阻滞的发生情况。在随访期间(平均5.5±2.4年),两组的PQ间期均无变化,心房组的心房刺激-Q间期或文氏阻滞点也无变化。心房组110例患者中有4例发生2至3度房室传导阻滞,需要升级起搏器(每年0.6%)。这4例患者中有2例在起搏器植入时存在右束支传导阻滞。
以100次/分和120次/分的心房起搏频率下的PQ间期、心房刺激-Q间期以及文氏阻滞点来评估,房室传导在长期随访期间保持稳定。因此,单腔心房起搏治疗是安全的,可推荐给无束支传导阻滞的病态窦房结综合征患者。